Tower Research Capital »

Ascentage Pharma Group Intl shares owned by Tower Research Capital

Quarter-by-quarter ownership of Ascentage Pharma Group Intl (AAPG) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Ascentage Pharma Group Intl

Tip: Access up to 7 years of quarterly data

All positions including Ascentage Pharma Group Intl held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascentage Pharma Group Intl by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 829 39.04

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Ascentage Pharma Group Intl

UBS Group
XY Capital
Point72
Tema Etfs
NEOS Investment Management
Citadel Advisors
Abc Arbitrage Sa
Mirae Asset Global Investments
Morgan Stanley
Tower Research Capital
Advisor Group Holdings
EverSource Wealth Advisors
Bell Investment Advisors

View all funds holding Ascentage Pharma Group Intl